[1]
P. Fontana, “Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab: A consensus statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network”, Swiss Med Wkly, vol. 150, no. 5153, p. w20422, Dec. 2020.